These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11257344)

  • 1. Measles elimination: old and new challenges?
    Muller CP
    Vaccine; 2001 Mar; 19(17-19):2258-61. PubMed ID: 11257344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of alternate immunization regimes for measles in vaccinated populations.
    Pabst HF; Boothe PM; Carson MM
    Vaccine; 1999 Jan; 17(2):182-92. PubMed ID: 9987153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
    Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
    Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles antibodies in women and infants in the vaccine era.
    Kacica MA; Venezia RA; Miller J; Hughes PA; Lepow ML
    J Med Virol; 1995 Feb; 45(2):227-9. PubMed ID: 7775944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
    Guerra FM; Crowcroft NS; Friedman L; Deeks SL; Halperin SA; Severini A; Hatchette TF; Bolotin S;
    Vaccine; 2018 Feb; 36(10):1248-1255. PubMed ID: 29398276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
    Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
    Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.
    Klingele M; Hartter HK; Adu F; Ammerlaan W; Ikusika W; Muller CP
    J Med Virol; 2000 Sep; 62(1):91-8. PubMed ID: 10935994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.
    Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC
    Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles.
    De Serres G; Joly JR; Fauvel M; Meyer F; Mâsse B; Boulianne N
    Vaccine; 1997; 15(6-7):620-3. PubMed ID: 9178461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting infants against measles in England and Wales: a review.
    Manikkavasagan G; Ramsay M
    Arch Dis Child; 2009 Sep; 94(9):681-5. PubMed ID: 19457878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis.
    Nic Lochlainn LM; de Gier B; van der Maas N; Strebel PM; Goodman T; van Binnendijk RS; de Melker HE; Hahné SJM
    Lancet Infect Dis; 2019 Nov; 19(11):1235-1245. PubMed ID: 31548079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related loss of maternal antibodies against measles in children in La Plata].
    del Buono MB; Vaschetti P; Iannicelli J; Silber R
    Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules.
    de Francisco A; Hall AJ; Unicomb L; Chakraborty J; Yunus M; Sack RB
    Vaccine; 1998 Apr; 16(6):564-8. PubMed ID: 9569466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.
    Pannuti CS; Morello RJ; Moraes JC; Curti SP; Afonso AM; Camargo MC; Souza VA
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):119-22. PubMed ID: 14715557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).
    Niewiesk S
    Vaccine; 2001 Mar; 19(17-19):2250-3. PubMed ID: 11257342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced seroconversion to measles in infants given vitamin A with measles vaccination.
    Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A
    Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.